Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating patients who
have recurrent chronic lymphocytic leukemia.